163 related articles for article (PubMed ID: 29923852)
1. Steroid Withdrawal Effects Following Long-term Topical Corticosteroid Use.
Sheary B
Dermatitis; 2018; 29(4):213-218. PubMed ID: 29923852
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
Hajar T; Leshem YA; Hanifin JM; Nedorost ST; Lio PA; Paller AS; Block J; Simpson EL;
J Am Acad Dermatol; 2015 Mar; 72(3):541-549.e2. PubMed ID: 25592622
[TBL] [Abstract][Full Text] [Related]
3. Topical Steroid Withdrawal: A Case Series of 10 Children.
Sheary B
Acta Derm Venereol; 2019 May; 99(6):551-556. PubMed ID: 30734047
[TBL] [Abstract][Full Text] [Related]
4. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
[TBL] [Abstract][Full Text] [Related]
5. Assessment of "corticophobia" as an indicator of non-adherence to topical corticosteroids: A pilot study.
Mueller SM; Itin P; Vogt DR; Walter M; Lang U; Griffin LL; Euler S
J Dermatolog Treat; 2017 Mar; 28(2):104-111. PubMed ID: 27396480
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use.
Smith SD; Farrugia LL; Harris V; Lee A; Carter SR; Blaszczynski A; Fischer G
J Dermatolog Treat; 2017 Nov; 28(7):642-646. PubMed ID: 28349719
[TBL] [Abstract][Full Text] [Related]
7. Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions.
Contento M; Cline A; Russo M
Am J Clin Dermatol; 2021 Nov; 22(6):837-851. PubMed ID: 34287768
[TBL] [Abstract][Full Text] [Related]
8. Topical corticosteroid addiction and withdrawal - An overview for GPs.
Sheary B
Aust Fam Physician; 2016 Jun; 45(6):386-8. PubMed ID: 27622228
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study.
Chi CC; Wang SH; Mayon-White R; Wojnarowska F
JAMA Dermatol; 2013 Nov; 149(11):1274-80. PubMed ID: 24005903
[TBL] [Abstract][Full Text] [Related]
10. Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream.
Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2014 Jul; 13(7):s77-83. PubMed ID: 25007376
[TBL] [Abstract][Full Text] [Related]
11. [Topical skin therapy with glucocorticoids--therapeutic index].
Luger T; Loske KD; Elsner P; Kapp A; Kerscher M; Korting HC; Krutmann J; Niedner R; Röcken M; Ruzicka T; Schwarz T
J Dtsch Dermatol Ges; 2004 Jul; 2(7):629-34. PubMed ID: 16281629
[No Abstract] [Full Text] [Related]
12. Topical steroid withdrawal through the lens of social media.
Bowe S; Masterson S; Murray G; Haugh I
Clin Exp Dermatol; 2022 Aug; 47(8):1554-1557. PubMed ID: 35340034
[TBL] [Abstract][Full Text] [Related]
13. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
Kircik LH
J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial comparing topical steroid application to wet versus dry skin in children with atopic dermatitis (AD).
Kohn LL; Kang Y; Antaya RJ
J Am Acad Dermatol; 2016 Aug; 75(2):306-11. PubMed ID: 27259583
[TBL] [Abstract][Full Text] [Related]
15. Topical steroid withdrawal: an emerging clinical problem.
Brookes TS; Barlow R; Mohandas P; Bewley A
Clin Exp Dermatol; 2023 Aug; 48(9):1007-1011. PubMed ID: 37119282
[TBL] [Abstract][Full Text] [Related]
16. Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.
Tan SY; Chandran NS; Choi EC
Clin Drug Investig; 2021 Oct; 41(10):835-842. PubMed ID: 34409577
[TBL] [Abstract][Full Text] [Related]
17. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey.
El Hachem M; Gesualdo F; Ricci G; Diociaiuti A; Giraldi L; Ametrano O; Occella C; Fortina AB; Milioto M; Arcangeli F; Simonetti O; Giancristoforo S; Calamelli E; Mazzatenta C; Neri I
Ital J Pediatr; 2017 Feb; 43(1):22. PubMed ID: 28245844
[TBL] [Abstract][Full Text] [Related]
18. Dermatologists' knowledge of and preferences regarding topical steroids.
Sandoval LF; Davis SA; Feldman SR
J Drugs Dermatol; 2013 Jul; 12(7):786-9. PubMed ID: 23884491
[TBL] [Abstract][Full Text] [Related]
19. Dermoscopy of topical steroid-dependent or damaged face: A cross-sectional study.
Sethi S; Chauhan P; Jindal R; Bisht YS
Indian J Dermatol Venereol Leprol; 2021; 88(1):40-46. PubMed ID: 34379967
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory features in acute generalized pustular psoriasis: a retrospective study of 34 patients.
Borges-Costa J; Silva R; Gonçalves L; Filipe P; Soares de Almeida L; Marques Gomes M
Am J Clin Dermatol; 2011 Aug; 12(4):271-6. PubMed ID: 21495733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
